MASS logo

908 Devices Inc. (MASS)

$9.39

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MASS

Market cap

$390458708

EPS

-0.66

P/E ratio

--

Price to sales

8.19

Dividend yield

--

Beta

0.656411

Price on MASS

Previous close

$9.19

Today's open

$9.26

Day's range

$8.79 - $9.43

52 week range

$5.03 - $13.35

Profile about MASS

CEO

Kevin J. Knopp

Employees

172

Headquarters

Burlington, MA

Exchange

NASDAQ Global Market

Shares outstanding

41582397

Issue type

Common Stock

MASS industries and sectors

Healthcare

Medical Equipment & Supplies

News on MASS

What 908 Devices (MASS) Said on Its Q3 Earnings Call

908 Devices NASDAQ: MASS reported record third-quarter revenue of $19 million, up 35% from a year earlier, and raised the low end of its 2026 revenue forecast as demand for its detection devices grew internationally.

news source

MarketBeat • Nov 10, 2026

news preview

908 Devices Inc. (MASS) Q3 2026 Earnings Call Transcript

908 Devices Inc. (MASS) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

908 Devices: Solid Q3 Results

908 Devices delivered strong Q3 results with 35% year-over-year revenue growth, beating analyst estimates, and achieving a record 308 device placements. Management raised the low end of its 2026 revenue guidance range to $68.5 million while reducing losses from year ago levels. MASS improved its financial profile, generating $1.3 million in free cash flow year to date, and ended Q3 with $99.1 million cash and no debt.

news source

Seeking Alpha • Nov 11, 2026

news preview

908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported financial results for the quarter ended September 30, 2026. "We had a strong third quarter, driven by our FTIR portfolio, with revenue growing 35% year-over-year to $19 million and device shipments reaching a new company record,” said Kevin J. Knopp, CEO and Co-founde.

news source

Business Wire • Nov 10, 2026

news preview

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.15 per share a year ago.

news source

Zacks Investment Research • Nov 10, 2026

news preview

908 Devices to Participate in the Stifel 2026 Healthcare Conference

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced that management will participate in a fireside chat at the Stifel 2026 Healthcare Conference on Wednesday, November 11, 2026 at 4:00 p.m. ET. A live webcast of the fireside chat will be available in the “Investors” section of the company's website at: www.908devices.c.

news source

Business Wire • Nov 4, 2026

news preview

Riverwater Micro Opportunities Strategy Q3 2026 Portfolio Activity

We initiated a position in 908 Devices, a maker of portable chemical detection instruments used by hazmat teams, law enforcement, firefighters, and the military. We initiated a position in Bowhead Specialty Holdings, a specialty insurer founded in 2020 by industry veteran Stephen Sills. We exited Coastal Financial in July. Our thesis rested on its role as a banking partner to fintech companies and the operating leverage those partnerships were expected to deliver this year.

news source

Seeking Alpha • Oct 30, 2026

news preview

908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the third quarter 2026 before market open on Tuesday, November 10, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors”.

news source

Business Wire • Oct 27, 2026

news preview

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026, in New York City.908 Devices' management is scheduled to present at 3:45 p.m. Eastern Time. The presentation is webcast and interested parties can register for th.

news source

Business Wire • Sep 1, 2026

news preview

908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates

908 Devices NASDAQ: MASS outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing recurring revenue.

news source

MarketBeat • Aug 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in 908 Devices Inc.

Open an M1 investment account to buy and sell 908 Devices Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MASS on M1